Cyclerion Therapeutics, Inc. (CYCN) Financials
Stock symbol CYCN is outdated, potentially delisted? Maybe it is available on other exchange?
Ticker CYCN was renamed to
KRSA
effective 2026-09-09.
CYCN Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 6.9 million | 1.8 million |
| March 31, 2026 | 8.5 million | 1.7 million |
| Dec. 31, 2025 | 10.0 million | 900000 |
| Sept. 30, 2025 | 10.4 million | 877000 |
CYCN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -1.4 million | 109000 |
| March 31, 2026 | -1.2 million | 58000 |
| Dec. 31, 2025 | -1.6 million | 95000 |
| Sept. 30, 2025 | -264000 | 118000 |
CYCN Net Income
No data available :(
CYCN Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 1.4 million | - | - |
| March 31, 2026 | 2.8 million | - | - |
| Dec. 31, 2025 | 3.2 million | - | - |
| Sept. 30, 2025 | 4.6 million | - | - |
CYCN Shares Outstanding
CYCN Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 66000 | - | 1.8 million | - |
| March 31, 2026 | 66000 | 730000 | 2.5 million | - |
| Dec. 31, 2025 | - | 519000 | 1.3 million | - |
| Sept. 30, 2025 | - | 348000 | 1.5 million | - |
CYCN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | - | 730000 |
| Dec. 31, 2025 | 1.0 million | - |
| Sept. 30, 2025 | 875000 | - |
CYCN
Price: $23.52
52 week price:
Earnings Per Share: -1.66 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 146600
Market Capitalization: 23.2 million